FDA+ channel feed – Endpoints News

FDA+ channel feed

Intercept is denied full FDA approval for Ocaliva, but claims it will keep drug on market

5 months ago

'Expertise is a real thing': FDA commissioner warns of political risk to agency

5 months ago

Rapt cuts immunology program following clinical holds

5 months ago

FDA records request lands Chinese API manufacturer on blocked import list

6 months ago

Soft RSV sales reveal a vaccine market failing to catch post-Covid momentum

6 months ago

FDA seeks to pull OTC nasal decongestant ingredient due to lack of efficacy

6 months ago

California voters say yes to restrictions around 340B spending

6 months ago

Biotech industry worries over potential for RFK Jr. ally as FDA pick

6 months ago

New Trump era could be a boon for biopharma M&A, dealmaking

6 months ago

Acadia lands $150M sale of rare pediatric PRV

6 months ago

FDA cites Mark Cuban's drug compounding center in Dallas with sterility, quality concerns

6 months ago

The election is Tuesday. What’s at stake for the pharma industry?

6 months ago

Rare disease biopharma companies weigh in on FDA's new innovation hub

6 months ago

FDA expands faster drug review pilot from supplemental to full applications

6 months ago

Following 2019 rejection, FDA adcomm votes against Lexicon's type 1 diabetes and CKD drug

6 months ago

Federal court backs FDA's approval of competitor to Jazz's sleep drug

6 months ago

FDA says all versions of Novo's GLP-1 weight loss drugs are now available

6 months ago

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

6 months ago

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

6 months ago

Lexicon's once-rejected diabetes drug is questioned again by FDA ahead of adcomm

6 months ago

Novartis expands Scemblix label to first-line CML patients

6 months ago

#HLTH24: GLP-1 compounding pharmacies took center stage at digital health’s biggest conference

6 months ago

Bipartisan letter questions FDA's 'narrow' interpretation for priority review vouchers

6 months ago

House Republicans push for more transparency on government-funded trial data

6 months ago

First page Previous page 10 11 121314 15 16 Next page Last page